| Fludarabine |
9800064 |
Fludara, Powder for solution for injection/infusion, 50, mg, Pack: 5 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
213.75 |
42.75 |
256.5 |
4% |
8.55 |
222.3 |
44.46 |
266.76 |
16% |
25 |
247.3 |
49.46 |
296.76 |
корекц. НСР-8180/22.02.2016 |
НСР-7770/28.12.2015 |
13.01.2016 |
13.01.2016 |
Активен |
2674 |
| Fludarabine |
9800064 |
Fludara, Powder for solution for injection/infusion, 50, mg, Pack: 5 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
221.79 |
44.36 |
266.15 |
4% |
8.87 |
230.66 |
46.13 |
276.79 |
16% |
25 |
255.66 |
51.13 |
306.79 |
|
НСР-3134/26.03.2014 |
18.04.2014 |
18.04.2014 |
Неактивен |
2674 |
| Fludarabine |
II-3091/07.10.2008 |
Fludara, Powder for solution for injection/infusion, 50, mg, Pack: 5 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
486.71 |
97.34 |
584.05 |
4% |
10 |
496.71 |
99.34 |
596.05 |
16% |
25 |
521.71 |
104.34 |
626.05 |
|
КЦРР-2766/20.03.2013. |
08.07.2013 |
08.07.2013 |
Неактивен |
2674 |
| Fludarabine |
II-3091/07.10.2008 / 9800064 |
Fludara, Powder for solution for injection/infusion, 50, mg, Pack: 5 |
Genzyme Europe B.V., Нидерландия |
Schering AG, Germany |
1098.55 |
219.71 |
1318.26 |
4% |
10 |
1108.55 |
221.71 |
1330.26 |
16% |
25 |
1133.55 |
226.71 |
1360.26 |
промяна на обстоятелства решение КЦPP-1970/10.01.2013 |
КЦ-2605/25.08.2011; прот. 24/11.07.2012 |
20.07.2012 |
20.07.2012 |
Неактивен |
2674 |
| Fludarabine |
II-3091/07.10.2008 / 9800064 |
Fludara, Powder for solution for injection/infusion, 50, mg, Pack: 5 |
Schering AG, Германия |
Schering AG, Germany |
1268.9 |
253.78 |
1522.68 |
6% |
15 |
1283.9 |
256.78 |
1540.68 |
18% |
30 |
1313.9 |
262.78 |
1576.68 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
2674 |
| Fludarabine |
20130217/10.07.2013 |
Fludarabine Actavis, Concentrate for solution for injection/infusion, 25 mg/ml-2 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
Actavis Italy S.p.A., Via Pasteur 10,20014 Nefviano (Milan), Италия |
48.9 |
9.78 |
58.68 |
4% |
1.96 |
50.86 |
10.17 |
61.03 |
16% |
7.82 |
58.68 |
11.74 |
70.42 |
|
НСР-7917/28.01.2016. |
12.02.2016 |
12.02.2016 |
Активен |
2352 |
| Fludarabine |
20130217/10.07.2013 |
Fludarabine Actavis, Concentrate for solution for injection/infusion, 25 mg/ml-2 ml, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
Actavis Italy S.p.A., Via Pasteur 10,20014 Nefviano (Milan), Италия |
95.52 |
19.1 |
114.62 |
4% |
3.82 |
99.34 |
19.87 |
119.21 |
16% |
15.28 |
114.62 |
22.92 |
137.54 |
|
НСР-2121/14.12.2013 |
30.12.2013 |
30.12.2013 |
Неактивен |
2352 |
| Fludarabine |
20100674 |
Fludarabine Actavis, Powder for solution for injection/infusion, 50, mg, Pack: 1 |
Actavis Group PTC ehf., Исландия |
S.C. Sindan-Pharma S.R.L. Romania |
97.34 |
19.47 |
116.81 |
4% |
3.89 |
101.23 |
20.25 |
121.48 |
16% |
15.57 |
116.8 |
23.36 |
140.16 |
Протокол № 110/25.03.2015 ; Промяна в обстоятелства НСР-6002/01.04.2015 |
КЦРР-905/28.06.2012 |
15.07.2012 |
15.07.2012 |
Активен |
1114 |
| Fludarabine |
20020574 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
458.31 |
91.66 |
549.97 |
4% |
10 |
468.31 |
93.66 |
561.97 |
16% |
25 |
493.31 |
98.66 |
591.97 |
|
НСР-5847/19.03.2015 |
02.04.2015 |
02.04.2015 |
Активен |
3687 |
| Fludarabine |
20020574 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
482.03 |
96.41 |
578.44 |
4% |
10 |
492.03 |
98.41 |
590.44 |
16% |
25 |
517.03 |
103.41 |
620.44 |
Оставена без разглеждане жалба от Комисия по прозрачност КП-42/16.04.2014 |
НСР-426/03.07.2013 |
02.07.2014 |
02.07.2014 |
Неактивен |
3687 |
| Fludarabine |
20020574 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
482.62 |
96.52 |
579.14 |
4% |
10 |
492.62 |
98.52 |
591.14 |
16% |
25 |
517.62 |
103.52 |
621.14 |
|
НСР-3013/12.03.2014 |
31.03.2014 |
31.03.2014 |
Неактивен |
3687 |
| Fludarabine |
II-1214/07.12.2007 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Genzyme Europe B.V., Нидерландия |
Bayer Pharma AG, Germany |
536.76 |
107.35 |
644.11 |
4% |
10 |
546.76 |
109.35 |
656.11 |
16% |
25 |
571.76 |
114.35 |
686.11 |
|
КЦРР-2765/20.03.2013. |
08.07.2013 |
08.07.2013 |
Неактивен |
3687 |
| Fludarabine |
II-1214/07,12,2007 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Genzyme Europe B.V., Нидерландия |
Schering AG, Germany |
749.16 |
149.83 |
898.99 |
4% |
10 |
759.16 |
151.83 |
910.99 |
16% |
25 |
784.16 |
156.83 |
940.99 |
промяна на обстоятелства решение КЦPP-1970/10.01.2013 |
КЦ-2605/25.08.2011; прот. 24/11.07.2012 |
20.07.2012 |
20.07.2012 |
Неактивен |
3687 |
| Fludarabine |
II-1214/07,12,2007 |
Fludara oral, Film coated tablet, 10, mg, Pack: 20 |
Schering AG, Германия |
Schering AG, Germany |
865.08 |
173.02 |
1038.1 |
6% |
15 |
880.08 |
176.02 |
1056.1 |
18% |
30 |
910.08 |
182.02 |
1092.1 |
|
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Неактивен |
3687 |
| Fludarabine |
II-1214/07,12,2007 |
Fludara oral, Film coated tablet, 10, mg, Pack: 15 |
Schering AG, Германия |
Schering AG, Germany |
668.54 |
133.71 |
802.25 |
4% |
10 |
678.54 |
135.71 |
814.25 |
16% |
25 |
703.54 |
140.71 |
844.25 |
цената се заличава КЦРР-1088/26.07.2012 |
КЦ-353/19.12.2008 |
22.01.2009 |
22.01.2009 |
Заличен |
360 |
| Flumazenil |
20100393 |
Flumazenil Pharmaselect, Solution for injection, 0,1 mg/ml - 5 ml, mg, Pack: 5 |
Pharmaselect International Beteiligungs GmbH, Австрия |
Pharmaselect International Beteiligungs GmbH |
57.83 |
11.57 |
69.4 |
4% |
2.31 |
60.14 |
12.03 |
72.17 |
16% |
9.25 |
69.39 |
13.88 |
83.27 |
цената е заличена с решение НСР-8653/31.03.2016 (в сила от 02.05.2016) |
НСР-5666/18.02.2015. |
05.03.2015 |
05.03.2015 |
Заличен |
3588 |
| Flumazenil |
20100393 |
Flumazenil Pharmaselect, Solution for injection, 0,1 mg/ml - 5 ml, mg, Pack: 5 |
Pharmaselect International Beteiligungs GmbH, Австрия |
Pharmaselect International Beteiligungs GmbH |
85.88 |
17.18 |
103.06 |
4% |
3.44 |
89.32 |
17.86 |
107.18 |
16% |
13.74 |
103.06 |
20.61 |
123.67 |
|
НСР-2212/20.12.2013 |
28.01.2014 |
28.01.2014 |
Неактивен |
3588 |
| Flumazenil |
II-10025/21.06.2010г |
Flumazenil Pharmaselect, Solution for injection, 0,1 mg/ml - 5 ml, mg, Pack: 5 |
Pharmaselect International Beteiligungs GmbH, Австрия |
Pharmaselect International Beteiligungs GmbH |
86.06 |
17.21 |
103.27 |
4% |
3.44 |
89.5 |
17.9 |
107.4 |
16% |
13.77 |
103.27 |
20.65 |
123.92 |
|
КЦРР-1414/05.09.2012 |
04.10.2012 |
04.10.2012 |
Неактивен |
3588 |
| Flunarizine |
20010619 |
FLUNARIZIN ACTAVIS, Capsule, hard, 5, mg, Pack: 20 |
Актавис EАД, България |
Балканфарма- Дупница АД; Балканфарма - Разград АД, България |
3.17 |
0.63 |
3.8 |
7% |
0.22 |
3.39 |
0.68 |
4.07 |
20% |
0.63 |
4.02 |
0.8 |
4.82 |
промяна на обстоятелства НСР-939/12.08.2013 |
НСР-565/23.07.2013 |
13.08.2013 |
13.08.2013 |
Активен |
2021 |
| Flunarizine |
II-13561/22.06.2006 |
FLUNARIZIN ACTAVIS, Capsule, hard, 5, mg, Pack: 20 |
Актавис EАД, България |
Балканфарма- Дупница АД |
2.88 |
0.58 |
3.46 |
7% |
0.2 |
3.08 |
0.62 |
3.7 |
20% |
0.58 |
3.66 |
0.73 |
4.39 |
|
КЦ-222/19.09.2008 |
21.10.2008 |
21.10.2008 |
Неактивен |
2021 |
| Fluorouracil |
20130261 |
Fluorouracil Accord, Solution for injection/infusion, 50 mg/ml - 20 ml, mg, Pack: 1 |
Accord Healthcare Limited, Обединено Кралство |
Accord Healthcare Limited, Обединено кралство |
3.91 |
0.78 |
4.69 |
7% |
0.27 |
4.18 |
0.84 |
5.02 |
20% |
0.78 |
4.96 |
0.99 |
5.95 |
|
НСР-2868/28.02.2014 |
02.03.2014 |
02.03.2014 |
Активен |
2512 |
| Fluorouracil |
II-4475/16.03.2009 |
FLUOROURACIL ACCORD, Solution for injection, 50 mg/ml - 10 ml, mg, Pack: 1 |
Accord Healthcare Limited, Обединено Кралство |
Camelog-BRS Ltd. -Унгария |
3.36 |
0.67 |
4.03 |
7% |
0.24 |
3.6 |
0.72 |
4.32 |
20% |
0.67 |
4.27 |
0.85 |
5.12 |
Цената се заличава с решение НСР-4118/10.07.2014 ( в сила от 02.08.2014) |
НСР-103/07.06.2013 |
03.07.2013 |
03.07.2013 |
Заличен |
1879 |
| Fluorouracil |
II-4475/16.03.2009 |
FLUOROURACIL ACCORD, Solution for injection, 50 mg/ml - 5 ml, mg, Pack: 1 |
Accord Healthcare Limited, Обединено Кралство |
Camelog-BRS Ltd. -Унгария |
1.92 |
0.38 |
2.3 |
7% |
0.13 |
2.05 |
0.41 |
2.46 |
20% |
0.38 |
2.43 |
0.49 |
2.92 |
Цената се заличава с решение НСР-4114/10.07.2014 ( в сила от 02.08.2014) |
КЦ-1050/22.07.2009 |
07.08.2009 |
07.08.2009 |
Заличен |
801 |
| Fluorouracil |
II-4475/16.03.2009 |
FLUOROURACIL ACCORD, Solution for injection, 50 mg/ml - 10 ml, mg, Pack: 1 |
Accord Healthcare Limited, Обединено Кралство |
Camelog-BRS Ltd. -Унгария |
3.83 |
0.77 |
4.6 |
7% |
0.27 |
4.1 |
0.82 |
4.92 |
20% |
0.77 |
4.87 |
0.97 |
5.84 |
|
КЦ-1050/22.07.2009 |
07.08.2009 |
07.08.2009 |
Неактивен |
1879 |
| Fluorouracil |
II-4608/07.04.2009 |
Fluorouracil Teva 50, Solution for injection, 50 mg/ml - 10 ml, mg, Pack: 1 |
Тева Фармасютикълс България ЕООД, България |
Pharmachemie BV Teva Group, The Netherlands |
3.27 |
0.65 |
3.92 |
9% |
0.29 |
3.56 |
0.71 |
4.27 |
22% |
0.72 |
4.28 |
0.86 |
5.14 |
цената е заличена с решение КЦРР-534/20.04.2012 |
КЦ-858/12.05.2009 |
02.06.2009 |
02.06.2009 |
Заличен |
725 |